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Objectives:  Understanding mechanistic pathways linking airborne particle exposure to 
cardiovascular health is important for causal inference and setting environmental standards.  We 
evaluated whether urinary albumin excretion, a subclinical marker of microvascular function 
which predicts cardiovascular events, was associated with ambient particle exposure. 
Methods: Urinary albumin and creatinine were measured among members of the Multi-Ethnic 
Study of Atherosclerosis at three visits during 2000-2004.  Exposure to PM2.5 and PM10 (µg/m3) 
was estimated from ambient monitors for one month, two months and two decades before visit 
one. We regressed recent and chronic (20 year) PM exposure on urinary albumin/creatinine ratio 
(UACR) (mg/g) and microalbuminuria at first exam, controlling for age; race/ethnicity; sex; 
smoking; secondhand smoke exposure; body mass index; and dietary protein (n=3,901). We also 
evaluated UACR changes and development of microalbuminuria between the first, and second 
and third visits which took place at 1.5 to 2 year intervals in relation to chronic PM exposure 
prior to baseline using mixed models.  
Results: Chronic and recent particle exposures were not associated with current UACR nor 
microalbuminuria {per 10 µg/m3 increment of chronic PM10 exposure, mean difference in log 
UACR = -0.02 (CI: -0.07, 0.03) and relative probability of having microalbuminuria = 0.92 (CI: 
0.77, 1.08)}  We found only weak evidence that albuminuria was accelerated among those 
chronically exposed to particles:  each 10 µg/m3 increment in chronic PM10 exposure was 
associated with a 1.14 relative probability of developing microalbuminuria over 3-4 years, 
though 95% confidence intervals (CI) included the null (0.96, 1.36).   
Conclusions:  UACR is not a strong mechanistic marker for air pollution’s possible influence on  
 




AUC  area under the curve 
BMI  body mass index 
CI   confidence interval 
EPA   Environmental Protection Agency 
ETS  environmental tobacco smoke 
km  kilometers 
µg/m3  micrograms per cubic meter 
MESA  Multi-Ethnic Study of Atherosclerosis 
PM  particulate matter 
PM10  particulate matter less than ten microns in aerodynamic diameter 
PM2.5  particulate matter less than 2.5  microns in aerodynamic diameter 
UACR  urinary albumin/creatinine ratio 




• Cardiovascular-cause hospitalizations and deaths have been linked to exposure to 
particulate air pollution, and we explored urinary albumin levels as a novel potential 
marker for pollution exposure’s contribution to development of cardiovascular disease. 
• In this study, albumin excretion was not linked with either short or long-term exposure to 
particulate air pollution, and does not appear to be a strong mechanistic marker for air 
pollution’s possible influence on cardiovascular health. 
Policy implications 
• Understanding biological mechanisms by which air pollution may contribute to 
cardiovascular morbidity and mortality is important for causal inference and helps form 
the evidence base for setting and enforcing protective air quality standards. 
• Studying air pollution’s effects on the cardiovascular health of a broadly representative 
multi-ethnic population is also important as many existing studies and cohorts do not 
reflect gender or race/ethnic diversity. 
• Although our study did not show associations between air pollution exposure and 
albumin, ample evidence exists that pollution adversely affects the cardiovascular system, 
so other study designs or mechanistic pathways may be required to detect the signal of air 




 on 30 January 2008 oem.bmj.comDownloaded from 
 
 4
Exposure to outdoor air pollution has been linked to a variety of adverse cardiovascular health 
outcomes.  Long-term exposure to particulate matter (PM) measured at outdoor monitors has 
been associated with cardiovascular mortality.[1, 2] Shorter-term PM exposures have been 
linked with impaired vascular, autonomic and endothelial function [3-5] and enhanced 
inflammation, both pulmonary and systemic.[6, 7]  Over time, repeated exposures to air pollution 
influencing these mechanisms may also lead to functional or structural changes in the 
cardiovascular system that may precipitate disease or even death.   
Indicators of subclinical cardiovascular function allow investigation of the role of 
pollution exposure in early development of cardiovascular disease.[8]  Urinary albumin excretion 
is one such indicator.  Albumin is a medium sized protein typically filtered in the kidney by 
membranes and not found in the urine.  However, when damage occurs in the glomerular 
endothelium and basement membrane, albumin is detectable in a urine sample.[9]  Although 
cutoff points have been traditionally used to define unhealthy levels of urinary albumin 
(microalbuminuria), urinary albumin excretion predicts cardiovascular risk in the general 
population, across the full range of urinary levels, even those below clinically defined 
dysfunction.[10-12]  Because leakage of albumin across membranes in the kidney can also 
reflect loss of arterial integrity in other vascular beds, albumin in urine can be a useful 
generalized marker of vascular function [12, 13] and a screening tool for risk of cardiovascular 
events.[10]  Urinary albumin has been linked with impaired endothelial function, peripheral 
vascular disease and other related conditions.[10, 12]   
Evidence that PM exposure is associated with development of albuminuria would suggest 
that changes in vascular function mediate associations between PM exposures and cardiovascular 
disease deaths or events.  PM exposure affects systemic vascular health indicators correlated 
with urinary albumin, implying a plausible link.  For example, environmental tobacco smoke 
(ETS), which has similar characteristics to ambient PM, has been associated with impaired 
endothelium-dependent dilation among healthy adults [14] and with vascular reactivity in 
rats.[15]  Ambient PM pollution has been linked with reduced endothelial function in humans,[5] 
and direct smoking can be a risk factor for impaired kidney function.[16]  This and other 
evidence implies that PM exposures may affect vascular health, via oxidative stress or other 
mechanisms.[17]  Urinary albumin excretion levels can change over periods of weeks, months or 
years, reflecting changes in systemic microvascular health and overall endothelial function.[16, 
18, 19]  Studying urinary albumin excretion allows testing of whether changes in systemic 
vascular function mediate the effects of PM exposure on cardiovascular risk. 
Using data from the Multi-Ethnic Study of Atherosclerosis (MESA), a large 
epidemiologic study of subclinical cardiovascular disease, we investigated whether ambient 
particle exposure is associated with urinary albumin excretion. The time lags with which PM 
exposure may affect vascular function (and albumin excretion) are unknown. Therefore we 
investigated both chronic (20 year) and recent (prior 30 and 60 day) exposures as predictors of 
albuminuria.  We also examined heterogeneity of these associations by race-ethnicity, age, sex, 
and study site.   
 







MESA is an ongoing longitudinal study of subclinical atherosclerosis funded by the National 
Heart Lung and Blood Institute.[20] Cohort members are 6,814 men and women aged 44-84 who 
were free of clinical cardiovascular disease at baseline.  Individuals were recruited from six field 
centers:  Baltimore, MD (Johns Hopkins); Chicago, IL (Northwestern); Forsyth County, NC 
(Wake Forest); Los Angeles, CA (University of California-Los Angeles); New York, NY 
(Columbia); and St. Paul, MN (University of Minnesota). Additional details on study design are 
provided elsewhere.[20] These analyses are based on data collected at the baseline visit (June 
2000-August 2002) and the second and third visits, which took place at 1.5 to 2 year intervals 
after baseline. 
 
Creatinine-adjusted urinary albumin excretion 
 
Our outcome of interest was creatinine-adjusted urinary albumin excretion.  For MESA 
participants, urinary albumin and creatinine levels (mg/dl) were measured in a spot sample taken 
in a fasting state at the baseline exam.  Samples were analyzed using nephelometry (albumin) 
and the rate Jaffe reaction (creatinine) at a central laboratory following standard quality 
assurance and control procedures and uniform storage and transport protocols.[21]  The urinary 
albumin/creatinine ratio (UACR) was calculated and adjusted for sex-specific differences in 
creatinine excretion by dividing the ratio by 0.68 for men because of their typically larger size 
and muscle mass.[22]  MESA participants were classified into four categories of urine albumin 
excretion (normal, high normal, microalbuminuria, and macroalbuminuria),  following Murtaugh 
et al.[23] 
 
Air pollution exposure 
 
Both recent and chronic PM exposures were investigated. Recent exposure was assigned based 
on the participant’s place of residence at the time of the baseline exam. Chronic exposure was 
estimated based on a residential history reported by each participant as part of an ancillary study 
to MESA. Participants reported all residential addresses since January 1982, including move 
dates (month and year). All addresses were geocoded, creating a file containing the residential 
location for each participant for each month between January 1982 and the date of the baseline 
exam.  
Data on air pollution from community monitors sited for regulatory purposes were 
obtained from the EPA Aerometric Information Retrieval Service (AIRS) database. For recent 
exposures we investigated mean concentrations, in µg/m3, of particles less than 10 and 2.5 
microns in aerodynamic diameter, respectively (PM10, PM2.5) for two time periods prior to the 
baseline exam: the average of the prior month, and average of the prior two months.  Particle 
monitors collected 24-hour integrated samples, some daily but most every third day. Based on 
reported residence of MESA participants at the time of the baseline exam, average monthly 
exposures were assigned using the nearest monitor with available data on that day (i.e., for each 
day of the prior month or two months).  The mean distance to the nearest monitor was 9 
kilometers (range 0.45-51 kilometers).   
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Longer term exposure was estimated for PM10 and PM2.5 in two ways.   The EPA 
monitoring network has made direct measurements of PM10 over a longer time frame than PM2.5, 
so one metric of cumulative 20 year PM10 exposure was estimated with data from those direct 
monitor readings.  The nearest monitor to each participant's residential address was used to 
compute monthly exposure averages from January 1982 to December 2002 (or the date of the 
baseline exam, if it came first).  An area under the curve (AUC) calculation is used to represent 
an average concentration over a time interval; 20 years in our study.  If we plot the monthly 
average estimated pollution concentration for each participant over the period of the study, and 
take the area under that curve, we have an estimate of his or her exposure in ug/m3. This method 
is an advantage over a simple average of concentrations over the time period because it allows 
interpolation of exposure over months with missing data, although this was a very small number 
in our dataset. However, we chose to use this AUC method for comparability with our imputed 
PM exposures (described next). The specific calculation was done as follows: Starting with the 
first available date, each average monthly PM10 value was multiplied by the number of months 
the subject was exposed to this value.  If PM10 information was missing (skips), the missing 
month(s) were given the average of the PM10 value from immediately before the skip and 
immediately after the skip.  This average value was multiplied by the size of the skip. All values 
were summed and then divided by the overall number of exposure months to get a cumulative 
monthly average over the 20 years.  The results were reported per 10 ug/m3 increments in PM10, 
as is standard in air pollution epidemiology.. 
 In addition to long-term PM10 estimates based solely on direct monitor readings, 
cumulative PM2.5 and PM10 exposures were imputed using a space-time model which yielded a  
three-dimensional exposure ‘surface’ of pollution concentrations over the continental U.S. for 
each month during the 20 year exposure period. Predictor variables for this estimated surface 
included: monitored PM levels and other covariates, including temperature and airport visibility 
data obtained from the National Climatic Data Center, total suspended particle measures from 
EPA’s network, and population density from the 1990 U.S. Census.[24]   This space-time model 
captured variation over time using trend, cyclic and autoregressive terms, and thin plate splines 
were used to capture variation over space.  With the nation-wide exposure surface created from 
the space-time model, each MESA participant was assigned a multiply-imputed cumulative 
exposure based on the months and locations represented in the residential history data. Multiple 
imputation has the advantage over using a single imputation in that the standard errors correctly 
reflect the level of uncertainty inherent in estimating missing values[25]; we followed standard 
multiple imputation procedures for this model. The overall fit of the space-time model with the 
observed data (for PM10) is characterized by an R-square of 58%. The model was also validated 
by deleting 10% of the observed values, imputing them and then comparing the distributions of 
imputed and observed values. A scatter plot of the imputed and observed values showed a scatter 
around a 45 degree line. The cumulative imputed 20 year exposures to PM2.5 and PM10 were 




During the baseline MESA exam, participants provided detailed information on personal 
characteristics (sex, age, race/ethnicity; cigarette smoking (never, former, current); and dietary 
protein). Height and weight were measured using standard procedures and used to calculate body 
mass index (BMI). MESA participants also reported ETS exposure in the year prior to the 
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baseline exam (were they in ‘close quarters’ with a person who smoked, at home, at work, in a 




We evaluated associations of  chronic and recent PM exposure with two outcomes measured at 
the MESA baseline visit: continuous log UACR and clinically defined micro- or macro-
albuminuria [23] (UACR > 25 mg/g) vs. normal levels.  We used scatter-plots to examine 
associations of the exposure measures with the baseline log UACR and calculated descriptive 
statistics and correlations between air pollution variables, and bivariate associations between 
covariates and log-transformed UACR.  We used multiple linear regressions to estimate 
associations of PM exposures with log UACR after adjustment for age, sex, race/ethnicity, BMI, 
percent dietary protein, cigarette smoking (never, former, current) , and ETS exposure (<1 
hour/week, >1 hour/ week). Although systolic and diastolic blood pressure, use of blood pressure 
medication, inflammatory markers, and diabetes status were available as potential covariates, we 
did not adjust for them, as they have been associated with air pollution exposure in previous 
studies and are potentially along the mechanistic pathway linking air pollution exposure to 
UACR. We expressed results as mean differences in log UACR at the baseline exam associated 
with a 10 ug/m3 increase in particle exposure. We used binomial regression [25] to evaluate 
whether air pollution was associated with microalbuminuria compared to normal  and high-
normal UACR levels, expressed as a relative probability per 10 ug/m3 increase in PM exposure. 
Analyses using imputed datasets used appropriate methods to account for uncertainty in the 
imputations.[26] 
To evaluate whether long-term PM exposure was associated with albumin changes over 
the three exam visits, we fit repeated measures model with random subject effects to estimate 
three-year changes in log UACR by levels of exposure. The repeat measures models included 
time in years, quartiles of long-term PM exposure (based on the directly estimated PM10 AUC 
measures), interactions between time and PM10 exposure category, and all the baseline covariates 
included in the cross-sectional analyses. We also examined sensitivity of results to the inclusion 
of time-by-baseline covariate interactions to allow the change over time to differ by covariate 
levels.  The three-year change in log UACR among participants in each exposure quartile was 
represented by the slope associated with time plus the corresponding time by exposure 
interaction.  We also estimated the relative probability that MESA participants who did not have 
microalbuminuria at baseline would develop the condition at exams 2 or 3, per 10 ug/m3 increase 
in estimated long-term exposure to directly-monitored PM10, using log-binomial regression 
models fit with SAS PROC GENMOD.[26]   
We examined heterogeneity of effects by sex; race/ethnicity; study site; and age in all 
models by including the corresponding interaction term(s) in fully adjusted models.  Albumin 
excretion differs by sex,[9] and associations between particle pollution and carotid intima-media 
thickness (CIMT), another subclinical indicator of cardiovascular function, were stronger among 
women.[27]  Associations between air pollution and heart rate variability have differed by race 
and ethnicity.[28]  Study site was evaluated because pollutant mix and composition (including 
oxidative properties of PM [29] can differ greatly by location.  Age may indicate differing 
susceptibility to the effects of air pollution on vascular function.  We defined effect modification 
as present if the p value for the interaction term was less than 0.01.   
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In sensitivity analyses, we examined these associations among individuals whose 
exposure to directly monitored PM2.5 and PM10 was estimated from monitors located within 10 
kilometers of their residences, for all exposure timeframes. For two decade exposures we also 
contrasted results using observed PM data to those obtained with multiply-imputed exposures 
from the space-time model. 
 Of the 6814 participants recruited to MESA, 5,229 had complete data on the outcome and 
clinical covariates used for the analyses and had completed the residential history questionnaire. 
Of these, 4,343 had geocodes available for all residential addresses between August 1982 and 
August 2002 and thus complete data on the chronic exposures. For comparability between the 
estimates for the long-term exposure and estimates for short-term exposure, analyses were 
further restricted to individuals for whom exposure could be assigned on all timescales. This 




Demographic and clinical characteristics of the sample are provided in Table 1.  Just over half 
the study sample were women, and the average age of participants was 63.  Fifty percent of the 
participants had ever smoked, and about 36% reported any ETS exposure.  On average, dietary 
protein made up approximately 16% of daily energy intake, and the mean BMI of the analysis 
population was 28.4.   The majority of the participants (78.7%) had UACR considered normal, 
and around 20% were classified as having microalbuminuria or high-normal levels, with just 1% 
at the macroalbuminuria level.  There were no important differences in key characteristics when 
the analysis sample was compared with the full MESA cohort (n = 6,814).  The study sample had 
a lower representation from St. Paul compared to the full sample (8.0% vs. 15.6%), and less 
Chinese and Hispanic participants than the full cohort (11.8% vs. 21.9%), because many of these 
people were recent immigrants whose chronic exposure could not be estimated. 




Table 1 Demographic and clinical characteristics and urinary albumin/creatinine ratio
for participants included in the analyses (n=3,901);  MESA 2000-2002
Age, years (mean±SD)  63.04 ± 9.9
% Female 52.4%








New York City 15.9%
St. Paul 8.0%
Body mass index, kg/m2 (mean±SD) 28.4 ± 5.3
Dietary protein (mean ±SD) Percent of total calories 16.0 + 3.7
Smoking status (% distribution) Never 50.2%
Former 38.4%
Current 11.4%
Environmental tobacco smoke (ETS) exposure None 64.1%
At least one hour per week 35.9%
Urinary albumin/creatinine ratio (UACR) mg/g a Visit 1 4.6 + 99.1
(median±SD) Visit 2 4.8 + 97.5
Visit 3 5.4 + 100.3
UACR categories (mg/g) (based on visit 1 levels)
Normal (< 15) 78.7%
High normal ( >15, <25) 10.3%
Microalbuminuria (>25, <250) 10.0%
Macroalbuminuria (> 250) 1.0%
a Exam1 N=3901, Exam2 N=3899, Exam3 N=3708  
 
Pollution levels measured the two decades and month prior to the MESA baseline exam 
are reported in Table 2.  The five-year increments that comprise the twenty-year cumulative 
PM10 assigned to participants reflect overall decreasing trends in PM10 levels across the U.S. 
during these decades.  
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Table 2.  Pollutant exposures for study participants by enrollment site for 
previous month and previous 20 years (based on residential history)
Pollutanta Exposure period Location N mean s.d. b
PM10 1982-2002 All sites 3901 34.7 7.0
1982-1987 All sites 3901 40.5 7.5
1988-1992 All sites 3901 38.0 8.9
1993-1997 All sites 3901 30.6 7.3
1998-2002 All sites 3901 29.7 6.9
Previous month All sites 3901 27.5 7.9
Baltimore 695 22.7 6.4
Chicago 818 31.7 7.9
Forsyth 733 22.4 5.2
Los Angeles 721 33.1 7.0
New York 621 25.2 6.1
St. Paul 313 31.3 4.0
PM2.5 Previous month All sites 3901 16.5 4.8
Baltimore 695 15.9 3.6
Chicago 818 16.7 3.9
Forsyth 733 15.2 3.4
Los Angeles 721 21.8 5.3
New York 621 15.5 2.8
St. Paul 313 10.4 2.5
a in units of µg/m3
b standard deviation  
In a linear regression model not including the pollutant values, UACR was significantly 
higher among: older participants; men; those of Chinese and Hispanic ethnicity compared to 
Caucasians; those with higher dietary protein intake, and those with higher BMI. Current 
smokers had an adjusted mean difference in UACR of 0.145 (95% CI: 0.033, 0.257) compared to 
never smokers. For former smokers compared to never smokers, the adjusted mean difference 
was 0.025 (95% CI: -0.048, 0.098).  The point estimate of the association of UACR with ETS 
was positive though the confidence intervals included the null value.  Scatter-plots of the 
albumin variables and pollution exposures revealed no apparent patterns of associations (not 
shown).    
Adjusted mean differences in log UACR associated with the pollutant exposures studied 
are shown in Table 3, for the total sample and the 2,611 participants living within 10 kilometers 
of a monitor for all exposure metrics.  The estimated associations are mostly negative, and for all 
but one of the models examined (60 day prior PM10 exposures), confidence intervals included the 
null.  Except for the association with imputed cumulative PM2.5 exposure, restricting to the 
population living in closer proximity to monitors pulled the point estimates of effect consistently 
closer to 0 or upward.  




Table 3. Adjusteda mean differences in log urinary albumin/creatinine ratio (UACR), 
(mg/g), per 10 µg/m3 increase in particulate matter among MESA participants seen 
at baseline visit from 2000-2002.
Pollutant and Mean
exposure period Populationb difference
PM2.5 
Prior 30 days full sample -0.017 -0.087 0.052
within 10 km 0.026 -0.067 0.119
Prior 60 days full sample -0.040 -0.121 0.042
within 10 km -0.013 -0.122 0.097
PM10
Prior 30 days full sample -0.042 -0.085 0.002
within 10 km -0.023 -0.079 0.034
Prior 60 days full sample -0.056 -0.106 -0.005
within 10 km -0.040 -0.106 0.025
Prior 2 decade exposure (1982-2002), from area under the curve for monthly levels
PM10 from nearest monitors full sample -0.019 -0.072 0.033
within 10 km 0.009 -0.067 0.085
Imputed exposuresc
PM10 full sample -0.002 -0.038 0.035
within 10 km 0.016 -0.033 0.066
PM2.5 full sample 0.002 -0.048 0.052
within 10 km -0.012 -0.076 0.053
a Adjustment: Baseline covariates (degrees of freedom): Age (1), gender (1), race (3), BMI (1),
cigarette status never-former-current (2),  environmental tobacco smoke exposure (1), 
percent dietary protein (1).
b Population: Full sample (n=3,901) had exposure estimated using nearest monitor, regardless
of distance from reported residential address. 2,611 participants lived within 10 km of monitors.
c Imputations from time-space model using monitor data, temperature and visibility (see text)
These imputations did not use the nearest monitor approach but are reported for the two
populations, defined by monitor proximity, for comparison with the other estimates.
95% Confidence interval
 
The adjusted relative probability of having microalbuminuria at baseline according to 
recent and chronic PM exposures are shown in Table 4.  As for the continuous UACR, the 
majority of the point estimates of effect were in the opposite of the hypothesized direction, and 
all but one of the estimates (for PM10 exposure in the prior 60 days) had a confidence interval 
including the null. 
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Table 4. Adjusteda relative prevalence of microalbuminuriab vs. high-normal and
normal levels (below 25 mg/g), per 10 µg/m3 increment in particulate matter, among 




Prior 30 days 0.94 0.77 1.16
Prior 60 days 0.90 0.71 1.14
PM10
Prior 30 days 0.88 0.76 1.02
Prior 60 days 0.83 0.70 0.99
Prior 2 decade exposure (1982-2002), from area under the curve for monthly levels
PM10 from nearest monitors 0.92 0.77 1.08
Imputed exposuresd
PM10 0.98 0.87 1.10
PM2.5 0.98 0.84 1.14
a Adjustment : Baseline covariates (degrees of freedom): Age (1), gender (1), race (3), BMI (1),
cigarette status (never-former-current) (2),  environmental tobacco smoke exposure (1), 
percent dietary protein (1)
b Albuminuria defined as UACR > 25 mg/g; macro-albuminuria > 250 mg/g
c Confidence interval
d Imputations from time-space model (see text)
95% CIc
 
Similarly,  when analyzing albumin levels at all three exams, the adjusted relative 
probability of developing microalbuminuria over the follow-up period associated with a 10 
µg/m3 difference in chronic PM10 exposure was elevated (1.14, 95% CI: 0.96, 1.36) but 
confidence intervals included the null, even when the population was restricted by monitor 
proximity (1.06, 95% CI: 0.84, 1.35).  Results using discrete survival analysis, with and without 
accounting for unequal exam intervals, were virtually identical to those reported above using 
binomial regression (not shown). 
The repeated-measures analysis of change in continuous log UACR by quartile of long-
term exposure showed a positive slope among all exposure quartiles (Table 5).  Restricting the 
models to participants living closer to ambient monitors did not have a consistent influence on 
the estimated slopes.  The slopes increased monotonically by increasing exposure quartile for the 
full-sample analyses, but the p-value for trend in that set of analyses was 0.42, and p-values for 
trend were similarly non-significant in the other model.  Inclusion of interaction terms between 
time and other covariates had little influence on the pattern or significance of the estimates.  
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Table 5.  Adjusteda mean 3 year change in log UACR (mg/g) by quartiles of 1982-2002 exposure to
PM10 from ambient monitors among MESA participants seen from 2000-2004.
Quartile of PM10 in µg/m3 Standard Test for Trend
Populationb from area under the curve Slope error (p-value)
full sample Range (18.5, <29.3) 0.147 0.024 0.42
Range (29.3, <33.1) 0.159 0.024
Range (33.1, <36.3) 0.163 0.024
Range (36.3, 55.7) 0.174 0.023
within 10 km Range (18.5, <29.3) 0.159 0.030 0.99
Range (29.3, <33.1) 0.155 0.031
Range (33.1, <36.3) 0.167 0.028
Range (36.3, 55.7) 0.152 0.036
a Adjustment variables: Baseline covariates (degrees of freedom): Age (1), gender (1), race (3), BMI (1), 
cigarette status never-former-current (2),  environmental tobacco smoke exposure (1), percent dietary protein
(1), and interaction terms between time (years) and PM10 exposure
b Population: The full sample (n = 3,901) had exposure estimated using nearest monitor, regardless of distance
from reported residential address. 2,611 participants lived within 10 km of monitors; 2,497 had exam 3 data.  
Heterogeneity by gender, age, race/ethnicity, and site was examined in fully adjusted 
models for both shorter-term exposures and 20 year PM10 exposure.  Interactions with PM 





Chronic and recent exposures to ambient particles were not associated with urinary albumin 
excretion in our sample.  There was only weak evidence that long-term exposure is associated 
with changes in microalbuminuria over time. This study is the first that we know of to examine 
albumin excretion as a subclinical indicator of the potential impact of air pollution on vascular 
function in a multi-ethnic population.  Our results suggest that urinary albumin is not a marker 
for a primary mechanism underlying the population-level observations of increased 
cardiovascular morbidity and mortality associated with air pollution exposure. Associations 
showed little evidence for effect modification by sex, race/ethnicity, study site and age.   
Although several studies have examined short-term pollution exposure and biomarkers of 
cardiovascular function, few studies of subclinical disease indicators and chronic pollution 
exposure exist.   Higher CIMT, a structural marker of subclinical cardiovascular disease, was 
seen among those living in areas of Los Angeles with higher estimated outdoor fine particle 
levels.[27]   Urinary albumin provides information about both functional and structural aspects 
of cardiovascular health, specifically marking smaller arteries, and complements this 
research.[30, 31] 
Urinary albumin excretion has traditionally been used as a screening tool to determine 
progression of deteriorating vascular function. Higher levels of albumin in urine result from 
physiologic changes including increased blood pressure in the glomerulus; and charge changes in 
the glomerular capillary basement membrane, possibly due to glycosylation of proteins in the 
membrane.[16]  Albumin levels are well-correlated with microvascular dysfunction.[19] 
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 Within-individual fluctuations in levels of albumin excretion occur (even including 
reductions in albumin excretion termed ‘regression’ from microalbuminuria to 
normoalbuminuria [18].  Predictors of acute changes in albumin excretion include protein intake, 
blood pressure, CRP, and insulin resistance [32-34] and changes have typically been evaluated at 
intervals of weeks to months.  Because of limited knowledge of the timescale of changes in 
urinary albumin excretion, we evaluated air pollution exposure at various timescales ranging 
from the potential effects of long-term cumulative exposures over 20 years, to more recent 
exposures in the prior two months. 
Albumin excretion measures have limitations. We had only a single spot urine sample for 
this study, and important variations may not be well captured by this technique, even with 
adjustment for creatinine.[21]  Urinary albumin excretion can be measured using a timed 
collection interval (considered the ‘gold standard’) or a single sample collected in a morning visit 
and adjusted for urinary creatinine, a metabolic byproduct of muscle.[35]  Adjusting the albumin 
concentration for creatinine levels is common practice for a spot sample, since creatinine 
concentration is fairly constant throughout the day and a good indicator of urine flow rate.[36]  
Although some variation by race exists in creatinine excretion, these differences have been 
evaluated only for Blacks and Whites, not Asians or Hispanics, so no race-specific adjustment 
was done, consistent with a previous analysis in the MESA cohort.[21]  In spite of limitations of 
spot samples,[37] many previous studies show their predictive power for cardiovascular events, 
and the UACR values in this population were associated with known risk factors for 
microalbuminuria in the expected direction.  
Measurement error in assigning environmental exposure to participants may have 
hampered our ability to detect associations with albumin, especially if any true causal effects are 
small. The ideal exposure metric would be a direct measure of personal air pollution exposure of 
MESA participants over the months and the two decades prior to the baseline exam.  No study 
has yet measured personal pollution exposure for such a long period of time.  While our PM 
measure is imperfect, previous studies have found associations between PM exposure and 
cardiovascular events and mortality using exposure measures cruder than ours (e.g., a single 
urban monitor, average of a few urban monitors), controlling for other known risk factors).[1, 2]  
Assigning exposures for or each month based on the nearest monitor is an improvement over a 
single-monitor approach.  Although strong evidence exists that daily fluctuations in ambient PM 
may precipitate cardiovascular events, the effect of PM in the process of developing 
cardiovascular disease is likely be a weaker signal and thus difficult to detect.    
This study did not account for exposures occurring during commuting or at the 
workplace.  However, ambient (background) PM tends to be a spatially homogeneous pollutant, 
relative to gaseous pollutants, so background exposures are likely to be fairly well-represented 
by ambient monitor measures [38] and the majority of MESA participants report spending 60% 
of their time at home or within two kilometers of their home.[39] We found no differences in the 
results when analyses were restricted to persons within 10 kilometers of a monitor for the full 
exposure period, or using space-time models to impute cumulative exposure to both PM size 
fractions.  Outdoor ambient measures of PM were more strongly associated with 
cardiopulmonary health outcomes than indoor or non-ambient personal exposures,[40] thus 
supporting the importance of our analysis using ambient PM measurements used to enforce 
community air pollution standards. 
A new study linked to the MESA cohort will allow much more detailed assessment of 
exposure using time-activity diaries and additional fixed and person-level monitoring. These data 
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will allow assessment of the relationship between short-term changes in PM and short-term 
changes in albumin excretion as cohort follow-up continues. More complex exposure assignment 
schemes, including incorporating distance to roadways and traffic counts, may yield different 
results in future efforts to model chronic exposure in MESA, and facilitate detection of the signal 
of air pollution’s impact on subclinical disease processes.  However, similar exposure 
assignment techniques to the present study have been used in landmark studies showing robust 
associations between long-term pollution exposure and mortality.[1, 2] 
Our longitudinal analyses examined the relationship between long-term cumulative 
exposure and subsequent changes in albumin excretion over a 3-4 year period. The objective was 
to determine whether long-term cumulative exposure places persons on a trajectory of 
deteriorating vascular function. These analyses examine the relationship between long-term 
exposure and within-person change. Although imprecise, the point estimates for development of 
microalbuminuria and slopes for change in continuously measured UACR were consistent with 
our hypothesis that vascular deterioration would be accelerated among those with higher chronic 




We examined associations between air pollution and UACR in a large, multi-ethnic sample with 
a substantial age range and ethnic diversity, and information on a variety of covariates.  Our 
objective was to explore a novel potential mechanistic pathway to aid in evaluating the causal 
links between pollution exposure and cardiovascular health seen in numerous epidemiologic 
studies. Although prior evidence from other studies suggests that particulate pollution exposure 
may contribute to progression of renal disease and vascular dysfunction over and above the 
standard risk factors, we did not see evidence for this in MESA.  Our findings do not strongly 
support the use of UACR as a marker of microvascular function to understand the cardiovascular 
effects of air pollution exposure, but pollution exposure may be associated with increased 
albumin excretion in vulnerable subgroups, or in studies with more detailed measures of personal 
exposures.   
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